Unum therapeutics inc. (UMRX)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Collaboration revenue

7,031

15,288

1,020

3,138

3,053

3,805

2,043

1,666

2,220

-

2,331

2,079

-

Collaboration revenue

-

-

-

-

-

-

-

-

-

-

-

-

1,827

Operating expenses:
Research and development

9,498

10,354

10,335

10,617

12,403

10,765

10,252

9,126

8,142

7,562

8,177

7,141

6,952

General and administrative

3,674

2,694

2,721

3,062

2,491

2,044

2,367

1,979

1,064

1,441

1,324

971

944

Total operating expenses

13,172

13,048

13,056

13,679

14,894

12,809

12,619

11,105

9,206

9,003

9,501

8,112

7,896

Loss from operations

-6,141

2,240

-12,036

-10,541

-11,841

-9,004

-10,576

-9,439

-6,986

-6,880

-7,170

-6,033

-6,069

Other income (expense):
Interest income

47

61

31

25

150

408

405

259

81

99

100

97

90

Other income, net

-

-

82

-

-

-10

3

157

170

-

70

73

-

Other income, net

-

-

-

-

-

-

-

-

-

-

-

-

40

Total other income (expense), net

47

57

113

25

150

398

408

416

251

190

170

170

130

Net loss

-6,094

2,297

-11,923

-10,516

-11,691

-8,606

-10,168

-9,023

-6,735

-6,690

-7,000

-5,863

-5,939

Accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

0

0

0

16

16

16

17

16

Net loss attributable to common stockholders

-

-

-11,923

-10,516

-

-8,606

-10,168

-9,023

-6,751

-6,706

-7,016

-5,880

-5,955

Net loss per common share, basic and diluted

-0.20

0.08

-0.39

-0.34

-0.39

-0.08

-0.34

-0.31

-0.66

-0.66

-0.69

-0.58

-0.58

Weighted average common shares outstanding, basic and diluted

30,136

30,671

30,661

30,505

30,083

30,342

29,879

29,155

10,204

10,194

10,192

10,190

10,190

Comprehensive loss:
Net loss

-6,094

2,297

-11,923

-10,516

-11,691

-8,606

-10,168

-9,023

-6,735

-6,690

-7,000

-5,863

-5,939

Other comprehensive income (loss):
Unrealized gains on marketable securities, net of tax of $0

-

0

0

2

10

12

-11

-6

9

8

19

-7

-12

Total other comprehensive income

-

0

0

2

10

12

-11

-6

9

8

19

-7

-12

Comprehensive loss

-6,094

2,297

-11,923

-10,514

-11,681

-8,594

-10,179

-9,029

-6,726

-6,682

-6,981

-5,870

-5,951